cvs health glp-1 receptor agonist weight management diabetes treatments A customizable approach to cost for GLP-1s Wegovy® Pill, First Oral GLP‑1
Description
[Google Scholar] 64
A few months later the drug gained authorisation in Canada, the European Union, Japan and then Australia in 2019
GLP-1 Agonist Medications Targeting GLP-1 has become a primary area of focus for cardiometabolic health, including weight management
If after a month someone isnt having significant side effects and isnt losing weight too quickly, then Ill increase the dose. Both medications are given as once-weekly injections using prefilled pens
Primary Research Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling
Challenges: A major challenge for Eli Lilly will be to effectively differentiate Mounjaro from semaglutide
